These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 22717644

  • 1. [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle].
    Santomauro M, Paoli-Valeri M, Fernández M, Camacho N, Molina Z, Cicchetti R, Valeri L, Dávila de Campagnaro E, Arata-Bellabarba G.
    Endocrinol Nutr; 2012; 59(6):346-53. PubMed ID: 22717644
    [Abstract] [Full Text] [Related]

  • 2. Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease.
    Papandreou D, Karabouta Z, Pantoleon A, Rousso I.
    Appetite; 2012 Dec; 59(3):939-44. PubMed ID: 23000278
    [Abstract] [Full Text] [Related]

  • 3. Improved oxidative stress and cardio-metabolic status in obese prepubertal children with liver steatosis treated with lifestyle combined with Vitamin E.
    D'Adamo E, Marcovecchio ML, Giannini C, de Giorgis T, Chiavaroli V, Chiarelli F, Mohn A.
    Free Radic Res; 2013 Mar; 47(3):146-53. PubMed ID: 23205728
    [Abstract] [Full Text] [Related]

  • 4. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.
    Reinehr T, Schmidt C, Toschke AM, Andler W.
    Arch Dis Child; 2009 Jun; 94(6):437-42. PubMed ID: 19224892
    [Abstract] [Full Text] [Related]

  • 5. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease.
    Pacifico L, Arca M, Anania C, Cantisani V, Di Martino M, Chiesa C.
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):1010-6. PubMed ID: 23018041
    [Abstract] [Full Text] [Related]

  • 6. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
    Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, Piemonte F, Marcellini M, Angulo P.
    Hepatology; 2008 Jul; 48(1):119-28. PubMed ID: 18537181
    [Abstract] [Full Text] [Related]

  • 7. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging.
    Radetti G, Kleon W, Stuefer J, Pittschieler K.
    Acta Paediatr; 2006 Jul; 95(7):833-7. PubMed ID: 16801180
    [Abstract] [Full Text] [Related]

  • 8. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
    Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, Königsrainer A, Königsrainer I, Kröber S, Niess A, Fritsche A, Häring HU, Stefan N.
    Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
    [Abstract] [Full Text] [Related]

  • 9. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
    Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, Haruta N, Fujino T, Aoyagi Y, Fukuizumi K, Yoshimoto T, Takemoto R, Miyahara T, Harada N, Hayata F, Nakashima M, Enjoji M.
    Scand J Gastroenterol; 2009 Sep; 44(4):471-7. PubMed ID: 19058085
    [Abstract] [Full Text] [Related]

  • 10. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, Marcellini M, Marchesini G.
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [Abstract] [Full Text] [Related]

  • 11. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
    Croci I, Byrne NM, Choquette S, Hills AP, Chachay VS, Clouston AD, O'Moore-Sullivan TM, Macdonald GA, Prins JB, Hickman IJ.
    Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
    [Abstract] [Full Text] [Related]

  • 12. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis.
    Reinehr T, Woelfle J, Wunsch R, Roth CL.
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2143-50. PubMed ID: 22438225
    [Abstract] [Full Text] [Related]

  • 13. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H, Moschen A.
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [Abstract] [Full Text] [Related]

  • 14. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement.
    Koot BG, van der Baan-Slootweg OH, Tamminga-Smeulders CL, Rijcken TH, Korevaar JC, van Aalderen WM, Jansen PL, Benninga MA.
    Arch Dis Child; 2011 Jul; 96(7):669-74. PubMed ID: 21518734
    [Abstract] [Full Text] [Related]

  • 15. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K, Resuli B, Petrela E, Malaj V, Jaze H.
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [Abstract] [Full Text] [Related]

  • 16. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice.
    Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, Sartorelli MR, Angulo P.
    Hepatology; 2006 Aug; 44(2):458-65. PubMed ID: 16871574
    [Abstract] [Full Text] [Related]

  • 17. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J, Lee S, Kim K, Yoo S, Sung E, Yim J.
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [Abstract] [Full Text] [Related]

  • 18. Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease.
    Sert A, Pirgon O, Aypar E, Yilmaz H, Odabas D.
    J Pediatr Endocrinol Metab; 2012 Sep; 25(9-10):927-34. PubMed ID: 23426822
    [Abstract] [Full Text] [Related]

  • 19. [The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai].
    Wan YP, Xu RY, Fang H, Lu LP, Zhang XM, Cai W.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Sep; 15(9):644-8. PubMed ID: 17903363
    [Abstract] [Full Text] [Related]

  • 20. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease.
    Pirgon O, Bilgin H, Tolu I, Odabas D.
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):189-95. PubMed ID: 21521307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.